GEN

Improved AAV Capsid Purification via High-Resolution Chromatography

Adeno-associated virus (AAV) capsids are an effective mechanism for delivering gene therapies intended for therapeutic use. A critical production step is the separation of full capsids from empty ones ...
GEN

Purification Option Eases the Bottlenecks in AAV Production

Adeno-associated viruses (AAVs) are used in nearly a dozen FDA-approved therapies and more than 900 R&D projects to deliver therapeutic payloads to cells. Yet, large-scale AAV production is still a ...
Business Wire

ChromaTan Receives a $2M Phase IIB NIH Grant to Develop a Fully Integrated Continuous Purification of AAV via BioRMB™ – a Column-Free Steady-State Continuous Elution ...

LOWER GWYNEDD, Pa.--(BUSINESS WIRE)--ChromaTan, a bioprocessing and biotools advanced biomanufacturing technology platform development company, is excited to announce the award of NIH IIB grant of $2M ...
Nature

Development of a scalable adeno-associated virus purification process

Adeno-associated Virus (AAV) has become the main vector for gene therapy, but scalable, cost-efficient, and robust filtration and chromatography-based processes are required for purification of AAV.